Frank Stokes

Chief Financial Officer

Frank Stokes (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $742K of CSTL (24,908 sh × $29.77, as filed), executed Aug 14.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Aug 14

Filed Aug 18

Median ADV $11.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

CSTL

Castle Biosciences, Inc. CSTL · 0 buys · 7 sells 7 filings

Recent filings

CSTLSALE Castle Biosciences, Inc. View filing → $742K
24,908 sh × $29.77
Exec Aug 14
Filed Aug 18 · 4:10 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $168K
6,001 sh × $27.98
Exec Mar 5
Filed Mar 9 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $145K
5,300 sh × $27.32
Exec Mar 3
Filed Mar 5 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $168K
4,496 sh × $37.45
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $189K
5,388 sh × $35.08
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $215K
8,046 sh × $26.70
Exec Feb 20 2025
Filed Feb 24 2025 · 5:30 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $183K
6,123 sh × $29.87
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET